The Americas Clinical Chemistry Analyzer Market is Estimated to Reach $1,496.4 Million By 2019 – A Report by MicroMarket Monitor

Share Article

The Americas Clinical Chemistry Analyzers Market is driven by the increasing ageing population & favorable medical insurance policies. http://www.micromarketmonitor.com/market/americas-clinical-chemistry-instruments-analyzer-2934211890.html

MicroMarket Monitor

MicroMarket Monitor

The key players of the Americas Clinical Chemistry Analyzers market are F. Hoffmann La-Roche (Switzerland) Siemens AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (US), Ortho Clinical Diagnostics (US).

The Americas Clinical Chemistry Analyzers market is estimated to reach $1,496.4 million by 2019, at a CAGR of 5.2% from 2014 to 2019.

Clinical chemistry analyzers are the devices/instruments that read and analyze the fluid present in the human body. These fluids are considered to be one of the vital parts in a human body. The main function of the fluids is to connect plethora of cells to transport essential minerals such as vitamins and calcium in arteries and veins. The content of minerals in body fluids must be accurate in order to avoid diseases like hyponatremia.

Browse through the TOC of Americas Clinical Chemistry Analyzers market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.
http://www.micromarketmonitor.com/market/americas-clinical-chemistry-instruments-analyzer-2934211890.html

The major drivers of clinical chemistry analyzers market in America are increasing healthcare expenditure, increasing ageing population & prevalence rate of lifestyle diseases, rise in rental agreements and increasing medical insurances.

The percentage of Americans aging 65 and older remains high, at 25.9%, and one adult in ten has diabetes in North America. New figures indicate that the number of people living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030. In the North American and Caribbean regions in 2011, an estimated 37.7 million people were living with diabetes and this is expected to increase enormously in the coming years. The U.S., with an estimated 23.7 million people, has the highest number of people with diabetes followed by Mexico, and Canada. In 2012, 29.1 million Americans, or 9.3% of the population, had suffered from diabetes.

Make an inquiry @ http://www.micromarketmonitor.com/contact/2934211890-inquery_before_buy.html

In 2010, after adjusting for population age differences, hospitalization rates for heart attack were 1.8 times higher among adults aged 20 years or older with diagnosed diabetes, than among adults without diagnosed diabetes.

U.S. is the highest contributor to the Clinical Chemistry Analyzers market in America, as it accounted for 27.6% in 2014.

Speak to Analyst @ http://www.micromarketmonitor.com/contact/2934211890-speak_to_analyst.html

This market is segmented and forecast on the basis of different type, end-user, and technology. There are two major types of clinical chemistry analyzers, namely semi-automated and fully automated. Hospitals, Diagnostic Centers, and Academic Research Institutes are included in this market report on the basis of end-user. Further, the market is segmented and forecast on the basis of major countries, such as the U.S., Canada, Mexico, Chile, and Rest of Americas (RoA).

This report also includes the market share, market metrics such as drivers, restraints and also the upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market.

Related Report:

Asia Pacific Clinical Chemistry Market

The Asia-Pacific clinical chemistry market is growing due to the ongoing developments in analytical laboratory automation, the swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoas says, hematology, flow cytometry, and microbiology, and finally, the geographical market expansion within emerging countries. The market in this region is growing in double digits and will continue to grow in future. China commanded the largest share (53%) at an estimated $516.81 million in 2013 and is expected to reach $1,047.2 million by 2018, at a CAGR of 16% from 2013 to 2018.

http://www.micromarketmonitor.com/market/asia-pacific-clinical-chemistry-1670445082.html

Report Subscription:

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
http://www.micromarketmonitor.com/offerings/subscription

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
@mmarketmonitor
Follow >
Micro Market Monitor
Like >
Visit website